Protein expression associated with early intrahepatic recurrence of hepatocellular carcinoma after curative surgery

Hideki Yokoo, Tadashi Kondo, Tetsuya Okano, Kazuaki Nakanishi, Michiie Sakamoto, Tomoo Kosuge, Satoru Todo, Setsuo Hirohashi

Research output: Contribution to journalArticle

16 Citations (Scopus)

Abstract

The poor prognosis of patients with hepatocellular carcinoma (HCC) is attributed to intrahepatic recurrence. To understand the molecular background of early intrahepatic recurrence, we conducted a global protein expression study. We compared the protein expression profiles of the primary HCC tissues of 12 patients who showed intrahepatic recurrence within 6 months post surgery with those of 15 patients who had no recurrence 2 years post surgery. Two-dimensional difference gel electrophoresis identified 23 protein spots, the intensity of which was highly associated with early intrahepatic recurrence. To validate the prediction performance of the identified proteins, we examined additional HCC tissues from 13 HCC patients; six with early intrahepatic recurrence and seven without recurrence. We found that all but one of the 13 patients were grouped according to their recurrence status based on the intensity of the 23 protein spots. Mass spectrometry identified 23 proteins corresponding to the spots. Although 13 of 23 have been previously reported to be correlated with HCC, their association with early intrahepatic recurrence had not been established. The identified proteins are involved in signal transduction pathways, glucose metabolism, cytoskeletal structure, cell adhesion, or function as antioxidants and chaperones. The identified proteins may be candidates for prognostic markers and contribute to the improvement of existing therapeutic strategies.

Original languageEnglish
Pages (from-to)665-673
Number of pages9
JournalCancer Science
Volume98
Issue number5
DOIs
Publication statusPublished - 2007 May

Fingerprint

Hepatocellular Carcinoma
Recurrence
Proteins
Two-Dimensional Difference Gel Electrophoresis
Cell Adhesion
Signal Transduction
Mass Spectrometry
Antioxidants
Glucose

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this

Protein expression associated with early intrahepatic recurrence of hepatocellular carcinoma after curative surgery. / Yokoo, Hideki; Kondo, Tadashi; Okano, Tetsuya; Nakanishi, Kazuaki; Sakamoto, Michiie; Kosuge, Tomoo; Todo, Satoru; Hirohashi, Setsuo.

In: Cancer Science, Vol. 98, No. 5, 05.2007, p. 665-673.

Research output: Contribution to journalArticle

Yokoo, Hideki ; Kondo, Tadashi ; Okano, Tetsuya ; Nakanishi, Kazuaki ; Sakamoto, Michiie ; Kosuge, Tomoo ; Todo, Satoru ; Hirohashi, Setsuo. / Protein expression associated with early intrahepatic recurrence of hepatocellular carcinoma after curative surgery. In: Cancer Science. 2007 ; Vol. 98, No. 5. pp. 665-673.
@article{5bcb0044e9fb437393cf9c07ddfa9089,
title = "Protein expression associated with early intrahepatic recurrence of hepatocellular carcinoma after curative surgery",
abstract = "The poor prognosis of patients with hepatocellular carcinoma (HCC) is attributed to intrahepatic recurrence. To understand the molecular background of early intrahepatic recurrence, we conducted a global protein expression study. We compared the protein expression profiles of the primary HCC tissues of 12 patients who showed intrahepatic recurrence within 6 months post surgery with those of 15 patients who had no recurrence 2 years post surgery. Two-dimensional difference gel electrophoresis identified 23 protein spots, the intensity of which was highly associated with early intrahepatic recurrence. To validate the prediction performance of the identified proteins, we examined additional HCC tissues from 13 HCC patients; six with early intrahepatic recurrence and seven without recurrence. We found that all but one of the 13 patients were grouped according to their recurrence status based on the intensity of the 23 protein spots. Mass spectrometry identified 23 proteins corresponding to the spots. Although 13 of 23 have been previously reported to be correlated with HCC, their association with early intrahepatic recurrence had not been established. The identified proteins are involved in signal transduction pathways, glucose metabolism, cytoskeletal structure, cell adhesion, or function as antioxidants and chaperones. The identified proteins may be candidates for prognostic markers and contribute to the improvement of existing therapeutic strategies.",
author = "Hideki Yokoo and Tadashi Kondo and Tetsuya Okano and Kazuaki Nakanishi and Michiie Sakamoto and Tomoo Kosuge and Satoru Todo and Setsuo Hirohashi",
year = "2007",
month = "5",
doi = "10.1111/j.1349-7006.2007.00441.x",
language = "English",
volume = "98",
pages = "665--673",
journal = "Cancer Science",
issn = "1347-9032",
publisher = "Wiley-Blackwell",
number = "5",

}

TY - JOUR

T1 - Protein expression associated with early intrahepatic recurrence of hepatocellular carcinoma after curative surgery

AU - Yokoo, Hideki

AU - Kondo, Tadashi

AU - Okano, Tetsuya

AU - Nakanishi, Kazuaki

AU - Sakamoto, Michiie

AU - Kosuge, Tomoo

AU - Todo, Satoru

AU - Hirohashi, Setsuo

PY - 2007/5

Y1 - 2007/5

N2 - The poor prognosis of patients with hepatocellular carcinoma (HCC) is attributed to intrahepatic recurrence. To understand the molecular background of early intrahepatic recurrence, we conducted a global protein expression study. We compared the protein expression profiles of the primary HCC tissues of 12 patients who showed intrahepatic recurrence within 6 months post surgery with those of 15 patients who had no recurrence 2 years post surgery. Two-dimensional difference gel electrophoresis identified 23 protein spots, the intensity of which was highly associated with early intrahepatic recurrence. To validate the prediction performance of the identified proteins, we examined additional HCC tissues from 13 HCC patients; six with early intrahepatic recurrence and seven without recurrence. We found that all but one of the 13 patients were grouped according to their recurrence status based on the intensity of the 23 protein spots. Mass spectrometry identified 23 proteins corresponding to the spots. Although 13 of 23 have been previously reported to be correlated with HCC, their association with early intrahepatic recurrence had not been established. The identified proteins are involved in signal transduction pathways, glucose metabolism, cytoskeletal structure, cell adhesion, or function as antioxidants and chaperones. The identified proteins may be candidates for prognostic markers and contribute to the improvement of existing therapeutic strategies.

AB - The poor prognosis of patients with hepatocellular carcinoma (HCC) is attributed to intrahepatic recurrence. To understand the molecular background of early intrahepatic recurrence, we conducted a global protein expression study. We compared the protein expression profiles of the primary HCC tissues of 12 patients who showed intrahepatic recurrence within 6 months post surgery with those of 15 patients who had no recurrence 2 years post surgery. Two-dimensional difference gel electrophoresis identified 23 protein spots, the intensity of which was highly associated with early intrahepatic recurrence. To validate the prediction performance of the identified proteins, we examined additional HCC tissues from 13 HCC patients; six with early intrahepatic recurrence and seven without recurrence. We found that all but one of the 13 patients were grouped according to their recurrence status based on the intensity of the 23 protein spots. Mass spectrometry identified 23 proteins corresponding to the spots. Although 13 of 23 have been previously reported to be correlated with HCC, their association with early intrahepatic recurrence had not been established. The identified proteins are involved in signal transduction pathways, glucose metabolism, cytoskeletal structure, cell adhesion, or function as antioxidants and chaperones. The identified proteins may be candidates for prognostic markers and contribute to the improvement of existing therapeutic strategies.

UR - http://www.scopus.com/inward/record.url?scp=34147140335&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=34147140335&partnerID=8YFLogxK

U2 - 10.1111/j.1349-7006.2007.00441.x

DO - 10.1111/j.1349-7006.2007.00441.x

M3 - Article

VL - 98

SP - 665

EP - 673

JO - Cancer Science

JF - Cancer Science

SN - 1347-9032

IS - 5

ER -